The Latest Breaking News from Trupanion

Trupanion shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 87.

Although pet health insurance specialist Trupanion operates in a relevant field, TRUP stock is completely unable to capitalize, posing serious concerns for investors.

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Benzinga Pro data, Trupanion (NASDAQ:TRUP) reported Q1 sales of $206.00 million. Earnings fell to a loss of $8.86 million, resulting in a 25.75% decrease from last quarter.

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

A hawkish Fed bodes well for the financial sector, including the insurance industry. But despite favorable impending interest rate hikes, fundamentally bleak insurance stocks Trupanion, Inc. (TRUP) and Lemonade, Inc. (LMND) look overvalued at their current price levels. So, we think it could be wise to avoid these stocks. Read…

Trupanion (NASDAQ:TRUP) reported its Q4 earnings results on Wednesday, February 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Trupanion (NASDAQ:TRUP) is set to give its latest quarterly earnings report on Wednesday, 2022-02-16. Here's what investors need to know before the announcement. Analysts estimate that Trupanion will report an earnings per share (EPS) of $-0.95.